Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
90
NMPA:90
Drug Approvals
Compound Glycyrrhizin for Injection
- Product Name
- 注射用复方甘草酸苷
- Approval Number
- 国药准字H20080026
- Approval Date
- Dec 20, 2022
NMPA
Cefpirome Sulfate for Injection
- Product Name
- 注射用硫酸头孢匹罗
- Approval Number
- 国药准字H20066550
- Approval Date
- Aug 11, 2021
NMPA
Cefpirome Sulfate for Injection
- Product Name
- 注射用硫酸头孢匹罗
- Approval Number
- 国药准字H20066847
- Approval Date
- Aug 11, 2021
NMPA
Potassium Sodium Pehydroandroandrographolide Succinate for Injection
- Product Name
- 注射用炎琥宁
- Approval Number
- 国药准字H20064443
- Approval Date
- Jul 9, 2021
NMPA
Potassium Sodium Pehydroandroandrographolide Succinate for Injection
- Product Name
- 注射用炎琥宁
- Approval Number
- 国药准字H20064442
- Approval Date
- Jul 9, 2021
NMPA
Cefonicid Sodium for Injection
- Product Name
- 注射用头孢尼西钠
- Approval Number
- 国药准字H20064636
- Approval Date
- Jul 2, 2021
NMPA
Cefonicid Sodium for Injection
- Product Name
- 注射用头孢尼西钠
- Approval Number
- 国药准字H20064635
- Approval Date
- Jul 2, 2021
NMPA
Thymopentin for Injection
- Product Name
- 注射用胸腺五肽
- Approval Number
- 国药准字H20065846
- Approval Date
- Jun 23, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
Clinical Trials
No trials found
News
No news found